THYROGLOBULIN (TG) - TUMOR MARKER - ANVISA Registration 10345162461

Access comprehensive regulatory information for THYROGLOBULIN (TG) - TUMOR MARKER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162461 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Mar 06, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162461
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162461
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Atellica IM Tireoglobulina (Tg)
Risk Class III

Registration Details

10345162461

25351478670202201

01449930000190

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Mar 06, 2023

06/03/2033

09/18/2025 19:00:01

Atellica IM Tireoglobulina (Tg)
Risk Class III

Registration Details

10345162461

25351478670202201

01449930000190

Company Information

Dates and Status

Mar 06, 2023

06/03/2033

09/18/2025 19:00:01